Lipsky AH, Lozier JN, Wiestner A. Response to Comment on Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. Haematologica [Internet]. 2016Feb.29 [cited 2026Nov.1];101(3):e124-e125. Available from: https://haematologica.org/article/view/7665